The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors

Increased proliferation and breast cancer risk has been observed in postmenopausal women receiving estrogen (E) + progestin hormone replacement therapy (HRT). Progestin action is mediated through two progesterone receptor (PR) isoforms, PRA and PRB, with unique transcriptional activity and function....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Oncol
Hlavní autoři: Aupperlee, Mark D., Kariagina, Anastasia, Zaremba, Nicole, Basson, Marc D., Schwartz, Richard C., Haslam, Sandra Z.
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press 2018
Témata:
Original article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884216/
https://ncbi.nlm.nih.gov/pubmed/29524829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.02.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky